Schröter C, Parzefall W, Schröter H, Schulte-Hermann R
Cancer Res. 1987 Jan 1;47(1):80-8.
Alpha-, beta-, and gamma-hexachlorocyclohexane (alpha-, beta-, gamma-HCH) isomers are widespread environmental pollutants; alpha-HCH can cause liver tumors in rats and mice. In the present study we have checked first the tumor-initiating activity of HCH using the appearance of phenotypically altered foci in female rat liver as an end point. Foci were identified by means of the gamma-glutamyltransferase (GGT) reaction and by morphological alterations. No evidence of initiating activity was found. Secondly, we have attempted to determine quantitatively the ability of HCH isomers to promote tumor development. For this purpose growth and phenotypic changes of foci were used as an end point. Rats received a single dose of N-nitrosomorpholine. Then five different doses of each HCH isomer or phenobarbital (PB) (as a positive control) were administered continuously via the diet for 4, 15, and 20 weeks. Both number and size of altered foci were enhanced by doses of 2 to 3 mg/kg or more of the three isomers; in addition, foci phenotypes showed a pronounced shift towards strong expression of GGT and sharp demarcation from the surrounding liver. Based on daily doses the three HCH isomers were approximately equipotent; based on concentrations in liver or adipose tissue, gamma-HCH was severalfold more effective than alpha- and beta-HCH. Thirdly, size and DNA and monooxygenase activities of the liver were determined. All three parameters were enhanced by HCH isomers and PB. However, no strict correlations were found. Rather, at the highest doses tested PB was the most effective inducer of monooxygenases, alpha-HCH was the most potent inducer of liver growth, and all three HCHs were more potent than PB as inducers of focal expansion. Thus, induction of liver growth appears to be associated with foci expansion (tumor promotion); however, neither liver growth nor monooxygenase induction can be used for quantitative predictions of foci expansion by chemical compounds. Finally, no-observed-effect levels were estimated for the parameters studied and are discussed in relation to human exposure.
α-、β-和γ-六氯环己烷(α-、β-、γ-HCH)异构体是广泛存在的环境污染物;α-HCH可在大鼠和小鼠体内引发肝肿瘤。在本研究中,我们首先以雌性大鼠肝脏中表型改变灶的出现为终点,检测了六氯环己烷的肿瘤启动活性。通过γ-谷氨酰转移酶(GGT)反应和形态学改变来识别这些病灶。未发现启动活性的证据。其次,我们试图定量测定六氯环己烷异构体促进肿瘤发展的能力。为此,以病灶的生长和表型变化为终点。大鼠接受单次剂量的N-亚硝基吗啉。然后,通过饮食连续给予每种六氯环己烷异构体或苯巴比妥(PB)(作为阳性对照)五个不同剂量,持续4周、15周和20周。三种异构体剂量为2至3mg/kg或更高时,改变灶的数量和大小均增加;此外,病灶表型显示出向GGT强表达的明显转变,并与周围肝脏有明显界限。基于每日剂量,三种六氯环己烷异构体大致等效;基于肝脏或脂肪组织中的浓度,γ-HCH比α-和β-HCH的效力高几倍。第三,测定了肝脏的大小、DNA和单加氧酶活性。三种六氯环己烷异构体和PB均增强了所有这三个参数。然而,未发现严格的相关性。相反,在测试的最高剂量下,PB是单加氧酶的最有效诱导剂,α-HCH是肝脏生长的最有效诱导剂,并且所有三种六氯环己烷作为病灶扩展诱导剂比PB更有效。因此,肝脏生长的诱导似乎与病灶扩展(肿瘤促进)有关;然而,肝脏生长和单加氧酶诱导都不能用于通过化合物定量预测病灶扩展。最后,对所研究的参数估计了未观察到效应的水平,并结合人类暴露情况进行了讨论。